You are here

CPX-351

Celator Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia

Fierce Biotech

Sat, 01/28/12 - 12:46 pm

acute myeloid leukemia

Celator(R) Pharmaceuticals Presents New Data on Two Nano-Scale Delivery Platforms at the American Asociation for Cancer Research

PR-CANADA

Sun, 04/25/10 - 11:47 am